Apira Science announced that it has received over-the-counter (OTC) clearance from the Food and Drug Adminstration (FDA) for its iGrow Hair Growth System to promote hair growth in women with Fitzpatrick skin phototypes I to IV and with Ludwig Baldness Scale Classifications of I to II.

The iGrow Hair Growth System uses low-level light therapy (LLLT) with using medical-grade LEDs and red laser diodes to increase hair counts. The FDA clearance was based on a double-blind, independently reviewed clinical trial in which female participants used the iGrow four times per week for 25 minutes per session. A 27% increase in hair counts was observed in four months.

RELATED: New Once-Daily Women’s Rogaine Foam Launched for Hair Loss

In September, the iGrow was granted OTC clearance from the FDA to promote hair growth in men. It is available online and in select retailers.

For more information visit iGrowLaser.com.